ARTAN Bio Raises $200,000 in Decentralized Funding to Advance Longevity Science Through Mutation-Specific Codon Suppression

ST. PETERSBURG, Fla., June 4, 2026 /PRNewswire/ -- ARTAN Bio, a longevity biotechnology company based in St. Petersburg, Florida, today announced the completion of a $200,000 seed raise. The raise will fund preclinical advancement of ARTAN Bio's proprietary engineered suppressor platform,...